Harvard Bioscience Inc (HBIO)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
LABORATORY ANALYTICAL INSTRUMENTS
CEO:
Jeffrey A. Duchemin
Employees:
519
84 OCTOBER HILL RD, HOLLISTON, MA 01746
5088938999

Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Data derived from most recent annual or quarterly report
Market Cap 157.5 Million Shares Outstanding41.23 Million Avg 30-day Volume 534.656 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.03
Price to Revenue2.122 Debt to Equity0.6411 EBITDA2.879 Million
Price to Book Value3.3533 Operating Margin-3.6513999999999998 Enterprise Value299.64 Million
Current Ratio2.184 EPS Growth0 Quick Ratio0.944
1 Yr BETA 1.0972 52-week High/Low 8.75 / 3.25 Profit Margin-5.3847
Operating Cash Flow Growth-123.4894 Altman Z-Score1.5501 Free Cash Flow to Firm -8.121 Million
Earnings Report2022-08-04
View SEC Filings from HBIO instead.

View recent insider trading info

Funds Holding HBIO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HBIO BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-05-17:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-28:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-28:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-25:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-09-30:
    Item 8.01: Other Events
  • 8-K: filed on 2021-08-09:
    Item 8.01: Other Events
  • 8-K: filed on 2021-08-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    70 Thousand total shares from 3 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GREEN JAMES W CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    2,301,582 2022-06-15 9

    ROSSI MICHAEL A. CHIEF FINANCIAL OFFICER

    • Officer
    277,508 2022-06-11 4

    EDRICK ALAN I

    • Director
    172,485 2022-05-24 3

    LOY BERTRAND

    • Director
    408,675 2022-05-24 3

    LOEWALD THOMAS W

    • Director
    223,885 2022-05-24 3

    EADE KATHERINE A.

    • Director
    239,700 2022-05-24 3

    OLSON KENNETH FLETCHER CHIEF OPERATING OFFICER

    • Officer
    155,595 2021-12-29 2

    KENNEDY JOHN F

    • Director
    323,344 2021-03-23 0

    STEELE SUSAN M.

    • Director
    49,400 2021-01-04 0

    SINGH YASH EXECUTIVE VICE PRESIDENT

    • Officer
    39,286 2019-10-31 0

    DUCHEMIN JEFFREY CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    No longer subject to file 2019-07-07 0

    UNNINAYAR KAMALAM CHIEF FINANCIAL OFFICER

    • Officer
    73,858 2019-03-07 0

    SUN YONG VP - COMMERCIAL OPERATIONS

    • Officer
    242,805 2019-01-01 0

    GAGNON ROBERT E. CHIEF FINANCIAL OFFICER

    • Officer
    321,169 2018-08-29 0

    UVEGES GEORGE

    • Director
    163,028 2018-03-07 0

    LEWIS EARL R

    • Director
    477,050 2018-01-02 0

    GREEN DAVID

    • Director
    1,160,467 2017-02-07 0

    HARTE NEAL J

    • Director
    106,399 2016-05-25 0

    SIBONY YOAV VP - GLOBAL SALES

    • Officer
    21,582 2015-08-03 0

    DISHMAN ROBERT A

    • Director
    No longer subject to file 2015-04-28 0

    GRAZIANO CHANE

    • 10% Owner
    No longer subject to file 2013-11-07 0

    LUSCINSKI SUSAN M CHIEF OPERATING OFFICER

    • Officer
    469,720 2013-11-01 0

    MCNAUGHTON THOMAS

    • FORMER CHIEF FINANCIAL OFFICER
    No longer subject to file 2013-11-01 0

    SKYSTONE ADVISORS LLC

    NELSON KERRY

    • 10% Owner
    No longer subject to file 2009-04-01 0

    HSO LIMITED PARTNERSHIP

    • 10% Owner
    No longer subject to file 2008-05-16 0

    NORIGE MARK A PRESIDENT, HARVARD APPARATUS

    • Officer
    75,000 2007-05-01 0

    CHICOYNE BRYCE ANTHONY CHIEF FINANCIAL OFFICER

    • Officer
    100,000 2007-05-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    GREEN JAMES W - Director - Officer CHIEF EXECUTIVE OFFICER

    2022-06-17 16:00:43 -0400 2022-06-15 P 30,000 $3.71 a 2,301,582 direct 3.1519 3.1519 2 0.0 1

    GREEN JAMES W - Director - Officer CHIEF EXECUTIVE OFFICER

    2022-06-14 16:07:05 -0400 2022-06-11 F 48,373 $3.95 d 2,271,582 direct -9.2643 -2.1798 0.0 1 -10.6267 3

    ROSSI MICHAEL A. - Officer CHIEF FINANCIAL OFFICER

    2022-06-14 16:08:47 -0400 2022-06-11 F 6,325 $3.95 d 277,508 direct -9.2643 -2.1798 0.0 1 -10.6267 3

    LOEWALD THOMAS W - Director

    2022-05-26 16:06:06 -0400 2022-05-24 A 38,259 a 223,885 direct -2.4 0.0 4.5333 5 -5.0667 3

    EDRICK ALAN I - Director

    2022-05-26 16:04:09 -0400 2022-05-24 A 38,259 a 172,485 direct -2.4 0.0 4.5333 5 -5.0667 3

    EADE KATHERINE A. - Director

    2022-05-26 16:02:09 -0400 2022-05-24 A 38,259 a 239,700 direct -2.4 0.0 4.5333 5 -5.0667 3

    LOY BERTRAND - Director

    2022-05-26 16:08:02 -0400 2022-05-24 A 47,493 a 340,209 direct -2.4 0.0 4.5333 5 -5.0667 3

    GREEN JAMES W - Director - Officer CHIEF EXECUTIVE OFFICER

    2022-05-10 17:13:49 -0400 2022-05-09 P 10,000 $3.40 a 2,319,955 direct -2.3499 -4.6997 -0.2611 12.7937 21 -14.3603 27

    GREEN JAMES W - Director - Officer CHIEF EXECUTIVE OFFICER

    2022-05-10 17:13:49 -0400 2022-05-06 P 30,000 $3.78 a 2,309,955 direct -2.3499 -4.6997 -0.2611 12.7937 21 -14.3603 27

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 22:15:03 UTC 0.859 0.711 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 21:45:03 UTC 0.859 0.711 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 21:15:04 UTC 0.859 0.711 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 20:45:03 UTC 0.8482 0.7218 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 20:15:03 UTC 0.8482 0.7218 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 19:45:03 UTC 0.8482 0.7218 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 19:15:03 UTC 0.8482 0.7218 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 18:45:03 UTC 0.7974 0.7726 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 18:15:04 UTC 0.7974 0.7726 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 17:45:03 UTC 0.7974 0.7726 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 17:15:03 UTC 0.7974 0.7726 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 16:45:03 UTC 0.708 0.862 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 16:15:03 UTC 0.708 0.862 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 15:45:03 UTC 0.708 0.862 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 15:15:03 UTC 0.708 0.862 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 14:45:03 UTC 1.1078 0.4622 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 14:15:03 UTC 1.1078 0.4622 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 13:45:03 UTC 1.1078 0.4622 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 13:15:03 UTC 1.1078 0.4622 250000
    HARVARD BIOSCIENCE INC HBIO 2022-06-24 12:45:03 UTC 1.1078 0.4622 250000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments